Insulin receptor structure and function in normal and pathological conditions - PubMed (original) (raw)
Review
Insulin receptor structure and function in normal and pathological conditions
A B Becker et al. Annu Rev Med. 1990.
Abstract
The insulin receptor is a large cell surface glycoprotein that concentrates insulin at the site of action and also initiates responses to insulin. The receptor is a disulfide-linked oligomer comprised of two alpha and two beta subunits. Signal transduction through the insulin receptor appears to require the activation of an intrinsic tyrosine-specific protein kinase activity. A variety of disorders, both acquired and genetic, are associated with the development of insulin resistance and are frequently the result of cellular defects in insulin receptor structure, function, and action. The recent cloning of several mutant receptors from patients with genetic forms of extreme insulin resistance has increased our understanding of insulin resistance on the molecular level.
Similar articles
- The nature and regulation of the insulin receptor: structure and function.
Czech MP. Czech MP. Annu Rev Physiol. 1985;47:357-81. doi: 10.1146/annurev.ph.47.030185.002041. Annu Rev Physiol. 1985. PMID: 2986534 Review. - [Insulin receptors, mechanism of signal transduction. Examples of abnormalities in states of insulin resistance].
Gherzi R, Briata P. Gherzi R, et al. Journ Annu Diabetol Hotel Dieu. 1993:11-21. Journ Annu Diabetol Hotel Dieu. 1993. PMID: 8392638 Review. French. No abstract available. - Regulation of insulin action at the cellular level.
Lönnroth P. Lönnroth P. J Intern Med Suppl. 1991;735:23-9. J Intern Med Suppl. 1991. PMID: 2043221 Review. - [Insulin signal transduction disorder and development of insulin resistance].
Huang DM, Lu FE. Huang DM, et al. Sheng Li Ke Xue Jin Zhan. 2003 Jul;34(3):212-6. Sheng Li Ke Xue Jin Zhan. 2003. PMID: 14628465 Review. Chinese. - An arginine to cysteine(252) mutation in insulin receptors from a patient with severe insulin resistance inhibits receptor internalisation but preserves signalling events.
Hamer I, Foti M, Emkey R, Cordier-Bussat M, Philippe J, De Meyts P, Maeder C, Kahn CR, Carpentier JL. Hamer I, et al. Diabetologia. 2002 May;45(5):657-67. doi: 10.1007/s00125-002-0798-5. Epub 2002 Apr 5. Diabetologia. 2002. PMID: 12107746
Cited by
- β-Adrenergic Receptor and Insulin Resistance in the Heart.
Mangmool S, Denkaew T, Parichatikanond W, Kurose H. Mangmool S, et al. Biomol Ther (Seoul). 2017 Jan 1;25(1):44-56. doi: 10.4062/biomolther.2016.128. Biomol Ther (Seoul). 2017. PMID: 28035081 Free PMC article. Review. - Recombinant human insulin-like growth factor I (rhIGF I) reduces hyperglycaemia in patients with extreme insulin resistance.
Schoenle EJ, Zenobi PD, Torresani T, Werder EA, Zachmann M, Froesch ER. Schoenle EJ, et al. Diabetologia. 1991 Sep;34(9):675-9. doi: 10.1007/BF00400998. Diabetologia. 1991. PMID: 1955101 - Insulin-like growth factor-1 in myocardial ischemia-reperfusion injury: A review.
Yan Z, Xing Z, Xue T, Zhao J, Li G, Xu L, Sun Q. Yan Z, et al. Medicine (Baltimore). 2024 Mar 1;103(9):e37279. doi: 10.1097/MD.0000000000037279. Medicine (Baltimore). 2024. PMID: 38428899 Free PMC article. Review. - Thiazolidinediones: effects on insulin resistance and the cardiovascular system.
Quinn CE, Hamilton PK, Lockhart CJ, McVeigh GE. Quinn CE, et al. Br J Pharmacol. 2008 Feb;153(4):636-45. doi: 10.1038/sj.bjp.0707452. Epub 2007 Oct 1. Br J Pharmacol. 2008. PMID: 17906687 Free PMC article. Review. - A complex of GRB2-dynamin binds to tyrosine-phosphorylated insulin receptor substrate-1 after insulin treatment.
Ando A, Yonezawa K, Gout I, Nakata T, Ueda H, Hara K, Kitamura Y, Noda Y, Takenawa T, Hirokawa N, et al. Ando A, et al. EMBO J. 1994 Jul 1;13(13):3033-8. doi: 10.1002/j.1460-2075.1994.tb06602.x. EMBO J. 1994. PMID: 8039498 Free PMC article.